Michael Robert Martin - Chief Business Officer, Aurinia Pharmaceuticals Inc

As of November 12, 2021


Michael Robert Martin Net Worth

  • Net worth is estimated to be at least $17.35M
  • Owns at least 55,861 units of Aurinia Pharmaceuticals Inc stock
  • Sold an estimated value of $12.79M in the last 7 months at Aurinia Pharmaceuticals Inc

Michael Robert Martin Trading

  • Largest purchase of shares was 116,000 units , worth over $798.8K on September 22, 2021
  • Largest sale of shares was 150,000 units , worth over $4.54M on November 12, 2021
  • In total has made about 11 transactions over 7 months
  • Usually trades in September, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Michael Robert Martin Mailing Address

  • Mailing address is #1203-4464 Markham Street Victoria A1 BC V8Z7X8 British Columbia, Canada

Aurinia Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Peter Greenleaf 2020 $673,400 - $1,534,992 $7,753,906 $707,070 $9,500 $10,678,868
Peter Greenleaf 2019 $438,258 $250,000 - $4,176,172 $368,137 $4,063 $5,236,630
Peter Greenleaf 2018 - - - - - - -
Joe Miller 2020 $279,545 $162,898 $461,040 $2,639,722 $167,727 $4,100 $3,715,032
Joe Miller 2019 - - - - - - -
Joe Miller 2018 - - - - - - -
Dennis Bourgeault 2020 $88,426 - - $399,825 $121,992 $93,472 $703,715
Dennis Bourgeault 2019 $270,145 - - $180,784 $126,205 $3,713 $580,847
Dennis Bourgeault 2018 $242,969 - - $351,432 $86,220 - $680,621
Max Colao 2020 $354,167 $153,125 $461,040 $3,664,488 $212,500 - $4,845,320
Max Colao 2019 - - - - - - -
Max Colao 2018 - - - - - - -
Max Donley 2020 $383,320 - $461,040 $2,249,253 $239,575 $4,615 $3,337,803
Max Donley 2019 $168,299 - - $598,154 $177,600 $1,850 $945,903
Max Donley 2018 - - - - - - -
Stephen Robertson 2020 $72,081 $75,684 $461,040 $2,907,909 $43,249 $2,416 $3,562,379
Stephen Robertson 2019 - - - - - - -
Stephen Robertson 2018 - - - - - - -
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1600620/000162828021009686/auriniapharmaceuticalsinc2.htm

Aurinia Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 150,000 units sold on November 12, 2021 by Michael Robert Martin worth over $4.54M
  • In the last 10 months, insiders at Aurinia Pharmaceuticals Inc sold an estimated value of $31.47M and bought an estimated value of $5.64M
  • The most active traders are Michael Robert Martin, Chief Business Officer,  Neil Solomons, Chief Medical Officer,  and Robert Bindert Huizinga, EVP Research
  • Insider trading is most common in June, with the busiest year in 2021

Aurinia Pharmaceuticals Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1